Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
Clinical trial NCT04375397 · COMPLETED
Trial details
- NCT number
- NCT04375397
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-06
- Primary completion
- 2021-05-10
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.